Rossari Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	922.14	442.02	251.7	691.98	374.77
Short-Term Investments	410.16	158.46	80.62	550.64	149.64
Trading Asset Securities	-	573.13	375.83	259.95	119.85
Cash & Short-Term Investments	1,332	1,174	708.15	1,503	644.26
Cash Growth	13.52%	65.73%	-52.87%	133.22%	-27.08%
Accounts Receivable	5,574	4,745	4,251	3,537	3,049
Other Receivables	-	2.82	1.54	5.41	1.16
Receivables	5,586	4,760	4,260	3,545	3,064
Inventory	4,045	3,551	2,823	1,885	1,899
Prepaid Expenses	-	20.11	12.48	18.31	49.49
Other Current Assets	1,396	914.46	631.99	263.62	436.26
Total Current Assets	12,359	10,419	8,436	7,214	6,093
Property, Plant & Equipment	7,338	4,937	3,619	3,267	3,480
Long-Term Investments	271.94	267.71	253.55	251.8	245.47
Goodwill	1,187	1,187	1,187	1,187	898.58
Other Intangible Assets	1,052	1,261	1,442	1,559	1,706
Long-Term Deferred Tax Assets	149.43	105.13	48.1	31.99	13.53
Other Long-Term Assets	530.03	784.41	736.46	164.48	130.46
Total Assets	22,888	18,962	15,722	13,676	12,567
Accounts Payable	3,235	2,863	2,191	1,810	1,862
Accrued Expenses	-	54.21	33.37	95.2	97.33
Short-Term Debt	-	861.12	625.28	290.12	-
Current Portion of Long-Term Debt	3,137	18.29	99.75	99.83	84.27
Current Portion of Leases	76.98	77.18	20.59	-	-
Current Income Taxes Payable	90	122.47	101.01	84.63	71.83
Current Unearned Revenue	-	3.61	3.9	4.19	4.48
Other Current Liabilities	1,357	1,365	1,173	1,101	827.22
Total Current Liabilities	7,896	5,366	4,247	3,485	2,947
Long-Term Debt	943.26	1,000	333.24	349.33	-
Long-Term Leases	202.53	223.07	109.06	-	-
Pension & Post-Retirement Benefits	82.6	52.57	34.24	21.82	17.82
Long-Term Deferred Tax Liabilities	430.46	465.67	514.72	587.2	689.49
Other Long-Term Liabilities	-	-	5.6	80.56	861.63
Total Liabilities	9,554	7,107	5,244	4,524	4,516
Common Stock	110.77	110.73	110.49	110.31	110.11
Additional Paid-In Capital	-	4,750	4,686	4,641	4,591
Retained Earnings	-	6,972	5,645	4,366	3,318
Comprehensive Income & Other	13,223	21.9	35.36	35.03	32.85
Shareholders' Equity	13,333	11,854	10,477	9,152	8,052
Total Liabilities & Equity	22,888	18,962	15,722	13,676	12,567
Total Debt	4,359	2,180	1,188	739.28	84.27
Net Cash (Debt)	-3,027	-1,006	-479.77	763.29	559.99
Net Cash Growth	-	-	-	36.30%	-36.62%
Net Cash Per Share	-54.63	-18.17	-8.67	13.79	10.15
Filing Date Shares Outstanding	55.38	55.36	55.25	55.16	55.06
Total Common Shares Outstanding	55.38	55.36	55.25	55.16	55.06
Working Capital	4,463	5,054	4,188	3,729	3,146
Book Value Per Share	240.76	214.12	189.65	165.92	146.24
Tangible Book Value	11,094	9,406	7,849	6,405	5,447
Tangible Book Value Per Share	200.32	169.90	142.07	116.13	98.93
Land	-	101.42	101.42	101.42	101.42
Buildings	-	1,697	1,666	1,693	1,670
Machinery	-	2,904	2,379	2,114	2,056
Construction In Progress	-	1,402	472.09	130.72	13.42
Leasehold Improvements	-	81.02	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.